| Phenotype and kinetics of SARS-CoV-2–specific T cells in COVID-19 patients with acute respiratory distress syndrome D Weiskopf, KS Schmitz, MP Raadsen, A Grifoni, NMA Okba, H Endeman, ... Science immunology 5 (48), eabd2071, 2020 | 957 | 2020 |
| SARS-CoV-2 variants of concern partially escape humoral but not T cell responses in COVID-19 convalescent donors and vaccine recipients D Geers, MC Shamier, S Bogers, G den Hartog, L Gommers, ... Science immunology 6 (59), eabj1750, 2021 | 530 | 2021 |
| Measles virus infection diminishes preexisting antibodies that offer protection from other pathogens MJ Mina, T Kula, Y Leng, M Li, RD De Vries, M Knip, H Siljander, ... Science 366 (6465), 599-606, 2019 | 407 | 2019 |
| Divergent SARS-CoV-2 Omicron–reactive T and B cell responses in COVID-19 vaccine recipients CH GeurtsvanKessel, D Geers, KS Schmitz, AZ Mykytyn, MM Lamers, ... Science immunology 7 (69), eabo2202, 2022 | 385 | 2022 |
| Early target cells of measles virus after aerosol infection of non-human primates K Lemon, RD de Vries, AW Mesman, S McQuaid, G van Amerongen, ... PLoS pathogens 7 (1), e1001263, 2011 | 249 | 2011 |
| Measles virus host invasion and pathogenesis BM Laksono, RD De Vries, S McQuaid, WP Duprex, RL De Swart Viruses 8 (8), 210, 2016 | 222 | 2016 |
| Measles immune suppression: lessons from the macaque model RD De Vries, S McQuaid, G Van Amerongen, S Yüksel, RJ Verburgh, ... Public Library of Science 8 (8), e1002885, 2012 | 198 | 2012 |
| Intranasal fusion inhibitory lipopeptide prevents direct-contact SARS-CoV-2 transmission in ferrets RD de Vries, KS Schmitz, FT Bovier, C Predella, J Khao, D Noack, ... Science 371 (6536), 1379-1382, 2021 | 190 | 2021 |
| Acyclovir-resistant corneal HSV-1 isolates from patients with herpetic keratitis R Duan, RD de Vries, ADME Osterhaus, L Remeijer, GMGM Verjans The Journal of infectious diseases 198 (5), 659-663, 2008 | 165 | 2008 |
| The RECOVAC immune-response study: the immunogenicity, tolerability, and safety of COVID-19 vaccination in patients with chronic kidney disease, on dialysis, or living with a … JSF Sanders, FJ Bemelman, AL Messchendorp, CC Baan, D van Baarle, ... Transplantation 106 (4), 821-834, 2022 | 148 | 2022 |
| Virus-specific T cells as correlate of (cross-) protective immunity against influenza AF Altenburg, GF Rimmelzwaan, RD de Vries Vaccine 33 (4), 500-506, 2015 | 148 | 2015 |
| Low levels of monkeypox virus-neutralizing antibodies after MVA-BN vaccination in healthy individuals LM Zaeck, MM Lamers, BE Verstrepen, TM Bestebroer, ME Van Royen, ... Nature medicine 29 (1), 270-278, 2023 | 146 | 2023 |
| Incomplete genetic reconstitution of B cell pools contributes to prolonged immunosuppression after measles VN Petrova, B Sawatsky, AX Han, BM Laksono, L Walz, E Parker, ... Science immunology 4 (41), eaay6125, 2019 | 146 | 2019 |
| Modified vaccinia virus ankara (MVA) as production platform for vaccines against influenza and other viral respiratory diseases AF Altenburg, JHCM Kreijtz, RD De Vries, F Song, R Fux, ... Viruses 6 (7), 2735-2761, 2014 | 142 | 2014 |
| Immunogenicity and reactogenicity of vaccine boosters after Ad26. COV2. S priming RSG Sablerolles, WJR Rietdijk, A Goorhuis, DF Postma, LG Visser, ... New England Journal of Medicine 386 (10), 951-963, 2022 | 135 | 2022 |
| DC-SIGN and CD150 have distinct roles in transmission of measles virus from dendritic cells to T-lymphocytes L de Witte, RD de Vries, M van der Vlist, S Yüksel, M Litjens, RL de Swart, ... PLoS pathogens 4 (4), e1000049, 2008 | 133 | 2008 |
| The pathogenesis of measles RD de Vries, AW Mesman, TBH Geijtenbeek, WP Duprex, RL de Swart Current opinion in virology 2 (3), 248-255, 2012 | 131 | 2012 |
| Morbillivirus infections: an introduction RD De Vries, WP Duprex, RL De Swart Viruses 7 (2), 699-706, 2015 | 125 | 2015 |
| Influenza B viruses: not to be discounted CE Van De Sandt, R Bodewes, GF Rimmelzwaan, RD De Vries Future microbiology 10 (9), 1447-1465, 2015 | 114 | 2015 |
| Human Langerhans cells capture measles virus through Langerin and present viral antigens to CD4+ T cells but are incapable of cross‐presentation M van der Vlist, L de Witte, RD de Vries, M Litjens, MAWP de Jong, ... European journal of immunology 41 (9), 2619-2631, 2011 | 113 | 2011 |
